Harnessing Organoids & Spheroids to Advance DDR Therapeutic Insights for Ewing Sarcoma

Time: 3:30 pm
day: Conference Day Two


• Highlighting the advantages of organoids and spheroids in recapitulating the tumour microenvironment, genetic heterogeneity, and therapeutic responses of Ewing sarcoma

• Discussing strategies to enhance the translational relevance of these models, such as incorporating patient-derived cells, genetic profiling, and integration of immune components

• Exploring innovative approaches, such as 3D bioprinting, to improve the predictive power and clinical translatability of Ewing sarcoma models